The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,725
Death Receptors: Signaling and Modulation
Ashkenazi, A., & Dixit, V. M. (1998) · Science · doi:10.1126/science.281.5381.1305 · Cited by 5,866
Muzio, M., Chinnaiyan, A. M., Kischkel, F. C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J. D., Zhang, M., Gentz, R., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81266-0 · Cited by 3,046
Two CD95 (APO‐1/Fas) signaling pathways
Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, K. J., Debatin, K., Krammer, P. H., & Peter, M. E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.6.1675 · Cited by 3,000
Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A., & Nagata, S. (1992) · Nature · doi:10.1038/356314a0 · Cited by 2,885
The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S.-I., Sameshima, M., Hase, A., Seto, Y., & Nagata, S. (1991) · Cell · doi:10.1016/0092-8674(91)90614-5 · Cited by 2,737
Suda, T., Takahashi, T., Golstein, P., & Nagata, S. (1993) · Cell · doi:10.1016/0092-8674(93)90326-l · Cited by 2,489
Chinnaiyan, A. M., O'Rourke, K., Tewari, M., & Dixit, V. M. (1995) · Cell · doi:10.1016/0092-8674(95)90071-3 · Cited by 2,431
Nicholson, D. W., & Thornberry, N. A. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01085-2 · Cited by 2,409
Boldin, M. P., Goncharov, T. M., Goltseve, Y. V., & Wallach, D. (1996) · Cell · doi:10.1016/s0092-8674(00)81265-9 · Cited by 2,292
Kischkel, F. C., Hellbardt, S., Behrmann, I., Germer, M., Pawlita, M., Krammer, P. H., & Peter, M. E. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00245.x · Cited by 2,184
Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege
Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R., & Ferguson, T. A. (1995) · Science · doi:10.1126/science.270.5239.1189 · Cited by 2,005
Monoclonal Antibody-Mediated Tumor Regression by Induction of Apoptosis
Trauth, B. C., Klas, C., Peters, A. M. J., Matzku, S., Möller, P., Falk, W., Debatin, K.-M., & Krammer, P. H. (1989) · Science · doi:10.1126/science.2787530 · Cited by 1,716
Control of TRAIL-Induced Apoptosis by a Family of Signaling and Decoy Receptors
Sheridan, J. P., Marsters, S. A., Pitti, R. M., Gurney, A., Skubatch, M., Baldwin, D., Ramakrishnan, L., Gray, C. L., Baker, K., Wood, W. I., et al. (1997) · Science · doi:10.1126/science.277.5327.818 · Cited by 1,664
Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)
Dhein, J., Walczak, H., Bäumler, C., Debatin, K.-M., & Krammer, P. H. (1995) · Nature · doi:10.1038/373438a0 · Cited by 1,609
Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation
Ju, S.-T., Panka, D. J., Cui, H., Ettinger, R., EI-Khatib, M., Sherr, D. H., Stanger, B. Z., & Marshak-Rothstein, A. (1995) · Nature · doi:10.1038/373444a0 · Cited by 1,499
An Antagonist Decoy Receptor and a Death Domain-Containing Receptor for TRAIL
Pan, G., Ni, J., Wei, Y.-F., Yu, G.-L., Gentz, R., & Dixit, V. M. (1997) · Science · doi:10.1126/science.277.5327.815 · Cited by 1,496
Fisher, G. H., Rosenberg, F. J., Straus, S. E., Dale, J. K., Middelton, L. A., Lin, A. Y., Strober, W., Lenardo, M. J., & Puck, J. M. (1995) · Cell · doi:10.1016/0092-8674(95)90013-6 · Cited by 1,465
Self-citationYonehara, S., Ishii, A., & Yonehara, M. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.5.1747 · Cited by 1,400
TUMOR NECROSIS FACTOR RECEPTOR AND Fas SIGNALING MECHANISMS
Wallach, D., Varfolomeev, E. E., Malinin, N. L., Goltsev, Y. V., Kovalenko, A. V., & Boldin, M. P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.331 · Cited by 1,312
Mutations in Fas Associated with Human Lymphoproliferative Syndrome and Autoimmunity
Rieux-Laucat, F., Le Deist, F., Hivroz, C., Roberts, I. A. G., Debatin, K. M., Fischer, A., & de Villartay, J. P. (1995) · Science · doi:10.1126/science.7539157 · Cited by 1,297
A novel domain within the 55 kd TNF receptor signals cell death
Tartaglia, L. A., Ayres, T. M., Wong, G. H. W., & Goeddel, D. V. (1993) · Cell · doi:10.1016/0092-8674(93)90464-2 · Cited by 1,288
Varfolomeev, E. E., Schuchmann, M., Luria, V., Chiannilkulchai, N., Beckmann, J. S., Mett, I. L., Rebrikov, D., Brodianski, V. M., Kemper, O. C., Kollet, O., et al. (1998) · Immunity · doi:10.1016/s1074-7613(00)80609-3 · Cited by 1,234
lpr And gld: Single Gene Models Of Systemic Autoimmunity And Lymphoproliferative Disease
Cohen, P. (1991) · Annual Review of Immunology · doi:10.1146/annurev.immunol.9.1.243 · Cited by 1,196
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
Gross, J. A., Johnston, J., Mudri, S., Enselman, R., Dillon, S. R., Madden, K., Xu, W., Parrish-Novak, J., Foster, D., Lofton-Day, C., et al. (2000) · Nature · doi:10.1038/35010115 · Cited by 1,174
A role for CD95 ligand in preventing graft rejection
Bellgrau, D., Gold, D., Selawry, H., Moore, J., Franzusoff, A., & Duke, R. C. (1995) · Nature · doi:10.1038/377630a0 · Cited by 1,155
TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL
Walczak, H. (1997) · The EMBO Journal · doi:10.1093/emboj/16.17.5386 · Cited by 1,130
Induction of apoptosis in mature T cells by tumour necrosis factor
Zheng, L., Fisher, G., Miller, R. E., Peschon, J., Lynch, D. H., & Lenardo, M. J. (1995) · Nature · doi:10.1038/377348a0 · Cited by 1,116
Self-citationBanner, D. W., D'Arcy, A., Janes, W., Gentz, R., Schoenfeld, H.-J., Broger, C., Loetscher, H., & Lesslauer, W. (1993) · Cell · doi:10.1016/0092-8674(93)90132-a · Cited by 1,104
An Induced Proximity Model for Caspase-8 Activation
Muzio, M., Stockwell, B. R., Stennicke, H. R., Salvesen, G. S., & Dixit, V. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.2926 · Cited by 1,023
lnterleukin-2 programs mouse αβ T lymphocytes for apoptosis
Lenardo, M. J. (1991) · Nature · doi:10.1038/353858a0 · Cited by 1,012
Self-citationBoldin, M. P., Varfolomeev, E. E., Pancer, Z., Mett, I. L., Camonis, J. H., & Wallach, D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.14.7795 · Cited by 993
MATURE T LYMPHOCYTE APOPTOSIS—Immune Regulation in a Dynamic and Unpredictable Antigenic Environment
Lenardo, M., Chan, F. K.-M., Hornung, F., McFarland, H., Siegel, R., Wang, J., & Zheng, L. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.221 · Cited by 943
Self-citationFADD: Essential for Embryo Development and Signaling from Some, But Not All, Inducers of Apoptosis
Yeh, W.-C., Pompa, J. L. D. L., McCurrach, M. E., Shu, H.-B., Elia, A. J., Shahinian, A., Ng, M., Wakeham, A., Khoo, W., Mitchell, K., et al. (1998) · Science · doi:10.1126/science.279.5358.1954 · Cited by 893
A Domain in TNF Receptors That Mediates Ligand-Independent Receptor Assembly and Signaling
Chan, F. K.-M., Chun, H. J., Zheng, L., Siegel, R. M., Bui, K. L., & Lenardo, M. J. (2000) · Science · doi:10.1126/science.288.5475.2351 · Cited by 856
Self-citationThe Role of c-FLIP in Modulation of CD95-induced Apoptosis
Scaffidi, C., Schmitz, I., Krammer, P. H., & Peter, M. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.3.1541 · Cited by 819
Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer
Pitti, R. M., Marsters, S. A., Lawrence, D. A., Roy, M., Kischkel, F. C., Dowd, P., Huang, A., Donahue, C. J., Sherwood, S. W., Baldwin, D. T., et al. (1998) · Nature · doi:10.1038/25387 · Cited by 783
Zhang, J., Cado, D., Chen, A., Kabra, N. H., & Winoto, A. (1998) · Nature · doi:10.1038/32681 · Cited by 706
TRAIL Receptors 1 (DR4) and 2 (DR5) Signal FADD-Dependent Apoptosis and Activate NF-κB
Schneider, P., Thome, M., Burns, K., Bodmer, J.-L., Hofmann, K., Kataoka, T., Holler, N., & Tschopp, J. (1997) · Immunity · doi:10.1016/s1074-7613(00)80401-x · Cited by 696
Fas Preassociation Required for Apoptosis Signaling and Dominant Inhibition by Pathogenic Mutations
Siegel, R. M., Frederiksen, J. K., Zacharias, D. A., Chan, F. K.-M., Johnson, M., Lynch, D., Tsien, R. Y., & Lenardo, M. J. (2000) · Science · doi:10.1126/science.288.5475.2354 · Cited by 662
Self-citationSignal Transduction by DR3, a Death Domain-Containing Receptor Related to TNFR-1 and CD95
Chinnaiyan, A. M., O'Rourke, K., Yu, G.-L., Lyons, R. H., Garg, M., Duan, D. R., Xing, L., Gentz, R., Ni, J., & Dixit, V. M. (1996) · Science · doi:10.1126/science.274.5289.990 · Cited by 654
A novel receptor for Apo2L/TRAIL contains a truncated death domain
Marsters, S. A., Sheridan, J. P., Pitti, R. M., Huang, A., Skubatch, M., Baldwin, D., Yuan, J., Gurney, A., Goddard, A. D., Godowski, P., et al. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00422-2 · Cited by 653
Wang, J., Zheng, L., Lobito, A., Chan, F. K.-M., Dale, J., Sneller, M., Yao, X., Puck, J. M., Straus, S. E., & Lenardo, M. J. (1999) · Cell · doi:10.1016/s0092-8674(00)80605-4 · Cited by 640
Self-citationBiochemical Mechanisms of IL-2–Regulated Fas-Mediated T Cell Apoptosis
Refaeli, Y., Van Parijs, L., London, C. A., Tschopp, J., & Abbas, A. K. (1998) · Immunity · doi:10.1016/s1074-7613(00)80566-x · Cited by 639
Expression of the functional soluble form of human fas ligand in activated lymphocytes.
Tanaka, M., Suda, T., Takahashi, T., & Nagata, S. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07096.x · Cited by 638
Cloning and Characterization of TRAIL-R3, a Novel Member of the Emerging TRAIL Receptor Family
Degli-Esposti, M. A., Smolak, P. J., Walczak, H., Waugh, J., Huang, C.-P., DuBose, R. F., Goodwin, R. G., & Smith, C. A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.7.1165 · Cited by 629
The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways
Kataoka, T., Budd, R. C., Holler, N., Thome, M., Martinon, F., Irmler, M., Burns, K., Hahne, M., Kennedy, N., Kovacsovics, M., et al. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00512-1 · Cited by 552
In Vivo Detection of Dendritic Cell Antigen Presentation to CD4+ T Cells
Ingulli, E., Mondino, A., Khoruts, A., & Jenkins, M. K. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.12.2133 · Cited by 546
T Cell Deletion in High Antigen Dose Therapy of Autoimmune Encephalomyelitis
Critchfield, J. M., Racke, M. K., Zúñiga-Pflücker, J. C., Cannella, B., Raine, C. S., Goverman, J., & Lenardo, M. J. (1994) · Science · doi:10.1126/science.7509084 · Cited by 524
Self-citationFas transduces activation signals in normal human T lymphocytes.
Alderson, M. R., Armitage, R. J., Maraskovsky, E., Tough, T. W., Roux, E., Schooley, K., Ramsdell, F., & Lynch, D. H. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2231 · Cited by 521
Caspase Activation Is Required for T Cell Proliferation
Kennedy, N. J., Kataoka, T., Tschopp, J., & Budd, R. C. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.12.1891 · Cited by 459
Zhang, X., Brunner, T., Carter, L., Dutton, R. W., Rogers, P., Bradley, L., Sato, T., Reed, J. C., Green, D., & Swain, S. L. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.10.1837 · Cited by 459
Kang, S.-M., Schneider, D. B., Lin, Z., Hanahan, D., Dichek, D. A., Stock, P. G., & Baekkeskov, S. (1997) · Nature Medicine · doi:10.1038/nm0797-738 · Cited by 450
Autoproteolytic Activation of Pro-Caspases by Oligomerization
Yang, X., Chang, H. Y., & Baltimore, D. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80032-5 · Cited by 434
Protection against Fas-dependent Thl-mediated apoptosis by antigen receptor engagement in B cells
Rothstein, T. L., Wang, J. K. M., Panka, D. J., Foote, L. C., Wang, Z., Stanger, B., Cui, H., Ju, S.-T., & Marshak-Rothstein, A. (1995) · Nature · doi:10.1038/374163a0 · Cited by 413
Rathmell, J. C., Townsend, S. E., Xu, J. C., Flavell, R. A., & Goodnow, C. C. (1996) · Cell · doi:10.1016/s0092-8674(00)81349-5 · Cited by 408
Thompson, J. S., Schneider, P., Kalled, S. L., Wang, L., Lefevre, E. A., Cachero, T. G., MacKay, F., Bixler, S. A., Zafari, M., Liu, Z.-Y., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.1.129 · Cited by 394
Alam, A., Cohen, L. Y., Aouad, S., & Sékaly, R.-P. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.12.1879 · Cited by 390
Regulation of the Proinflammatory Effects of Fas Ligand (CD95L)
Chen, J.-J., Sun, Y., & Nabel, G. J. (1998) · Science · doi:10.1126/science.282.5394.1714 · Cited by 383
Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI
Marsters, S. A., Yan, M., Pitti, R. M., Haas, P. E., Dixit, V. M., & Ashkenazi, A. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00566-2 · Cited by 374
Sneller, M. C., Wang, J., Dale, J. K., Strober, W., Middelton, L. A., Choi, Y., Fleisher, T. A., Lim, M. S., Jaffe, E. S., Puck, J. M., et al. (1997) · Blood · doi:10.1182/blood.v89.4.1341 · Cited by 371
Self-citationAllison, J., Georgiou, H. M., Strasser, A., & Vaux, D. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3943 · Cited by 366
Membrane Oligomerization and Cleavage Activates the Caspase-8 (FLICE/MACHα1) Death Signal
Martin, D. A., Siegel, R. M., Zheng, L., & Lenardo, M. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.8.4345 · Cited by 358
Self-citationA death-domain-containing receptor that mediates apoptosis
Kitson, J., Raven, T., Jiang, Y.-P., Goeddel, D. V., Giles, K. M., Pun, K.-T., Grinham, C. J., Brown, R., & Farrow, S. N. (1996) · Nature · doi:10.1038/384372a0 · Cited by 337
The mouse fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster
Lynch, D. H., Watson, M. L., Alderson, M. R., Baum, P. R., Miller, R. E., Tough, T., Gibson, M., Davis-Smith, T., Smiths, C. A., Hunter, K., et al. (1994) · Immunity · doi:10.1016/1074-7613(94)90106-6 · Cited by 331
Self-Tolerance Checkpoints in B Lymphocyte Development
(1995) · Advances in Immunology · doi:10.1016/s0065-2776(08)60633-1 · Cited by 328
A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease.
Sneller, M. C., Straus, S. E., Jaffe, E. S., Jaffe, J. S., Fleisher, T. A., Stetler-Stevenson, M., & Strober, W. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115867 · Cited by 301
An Inherited Disorder of Lymphocyte Apoptosis: The Autoimmune Lymphoproliferative Syndrome
Straus, S. E., Sneller, M., Lenardo, M. J., Puck, J. M., & Strober, W. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-7-199904060-00020 · Cited by 294
Self-citationIdentification and functional characterization of DR6, a novel death domain‐containing TNF receptor
Pan, G., Bauer, J. H., Haridas, V., Wang, S., Liu, D., Yu, G., Vincenz, C., Aggarwal, B. B., Ni, J., & Dixit, V. M. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00791-1 · Cited by 291
Characterization of two receptors for TRAIL1
Schneider, P., Bodmer, J.-L., Thome, M., Hofmann, K., Holler, N., & Tschopp, J. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01231-3 · Cited by 290
Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape
Restifo, N. P. (2000) · Nature Medicine · doi:10.1038/74955 · Cited by 251
Kiener, P. A., Davis, P. M., Starling, G. C., Mehlin, C., Klebanoff, S. J., Ledbetter, J. A., & Liles, W. C. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.8.1511 · Cited by 248
Xia, X.-Z., Treanor, J., Senaldi, G., Khare, S. D., Boone, T., Kelley, M., Theill, L. E., Colombero, A., Solovyev, I., Lee, F., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.1.137 · Cited by 248
Modularity in the TNF-receptor family
Naismith, J. H., & Sprang, S. R. (1998) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01164-x · Cited by 248
Receptor-stimulated death pathway is opened by antigen in mature T cells.
Russell, J. H., White, C. L., Loh, D. Y., & Meleedy-Rey, P. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.6.2151 · Cited by 246
Chu, J. L., Drappa, J., Parnassa, A., & Elkon, K. B. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.2.723 · Cited by 245
Wu, Y., Bressette, D., Carrell, J. A., Kaufman, T., Feng, P., Taylor, K., Gan, Y., Cho, Y. H., Garcia, A. D., Gollatz, E., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005224200 · Cited by 245
NMR structure and mutagenesis of the FADD (Mort1) death-effector domain
Eberstadt, M., Huang, B., Chen, Z., Meadows, R. P., Ng, S.-C., Zheng, L., Lenardo, M. J., & Fesik, S. W. (1998) · Nature · doi:10.1038/31972 · Cited by 239
Self-citationPropriocidal apoptosis of mature T lymphocytes occurs at S phase of the cell cycle
Boehme, S. A., & Lenardo, M. J. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230724 · Cited by 239
Self-citationRequirement of Fas for the Development of Autoimmune Diabetes in Nonobese Diabetic Mice
Itoh, N., Imagawa, A., Hanafusa, T., Waguri, M., Yamamoto, K., Iwahashi, H., Moriwaki, M., Nakajima, H., Miyagawa, J., Namba, M., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.4.613 · Cited by 236
Perlman, H., Pagliari, L. J., Georganas, C., Mano, T., Walsh, K., & Pope, R. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.11.1679 · Cited by 222
Loci predisposing to autoimmunity in MRL-Fas lpr and C57BL/6-Faslpr mice.
Vidal, S., Kono, D. H., & Theofilopoulos, A. N. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1817 · Cited by 215
Screaton, G. R., Xu, X.-N., Olsen, A. L., Cowper, A. E., Tan, R., McMichael, A. J., & Bell, J. I. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4615 · Cited by 211
Autoimmune Lymphoproliferative Syndrome with Defective Fas: Genotype Influences Penetrance
Jackson, C. E., Fischer, R. E., Hsu, A. P., Anderson, S. M., Choi, Y., Wang, J., Dale, J. K., Fleisher, T. A., Middelton, L. A., Sneller, M. C., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302333 · Cited by 210
Self-citationCrystallographic analysis of CD40 recognition and signaling by human TRAF2
McWhirter, S. M., Pullen, S. S., Holton, J. M., Crute, J. J., Kehry, M. R., & Alber, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8408 · Cited by 195
Cell death: TRAIL and its receptors
GOLSTEIN, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)90000-1 · Cited by 194
Identification of a ligand for the death-domain-containing receptor Apo3
Marsters, S. A., Sheridan, J. P., Pitti, R. M., Brush, J., Goddard, A., & Ashkenazi, A. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70204-0 · Cited by 187
Differential ability of T cell subsets to undergo activation-induced cell death
Varadhachary, A. S., Perdow, S. N., Hu, C., Ramanarayanan, M., & Salgame, P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.11.5778 · Cited by 183
Papoff, G., Hausler, P., Eramo, A., Pagano, M. G., Di Leve, G., Signore, A., & Ruberti, G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.38241 · Cited by 183
Martin, D. A., Zheng, L., Siegel, R. M., Huang, B., Fisher, G. H., Wang, J., Jackson, C. E., Puck, J. M., Dale, J., Straus, S. E., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4552 · Cited by 181
Self-citationPeter, M. E., Kischkel, F. C., Scheuerpflug, C. G., Medema, J. P., Debatin, K., & Krammer, P. H. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270523 · Cited by 166
The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations
Vaishnaw, A. K., Orlinick, J. R., Chu, J., Krammer, P. H., Chao, M. V., & Elkon, K. B. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5121 · Cited by 154
Sabelko-Downes, K. A., Cross, A. H., & Russell, J. H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.8.1195 · Cited by 134
Zaks, T. Z., Chappell, D. B., Rosenberg, S. A., & Restifo, N. P. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3273 · Cited by 123
Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis
Suvannavejh, G. C., Canto, M. C. D., Matis, L. A., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8561 · Cited by 121
Feldman, M. A., Taylor, P. C., Paleolog, E. M., Brennan, F. M., & Maini, R. N. (1998) · Transplantation Proceedings · doi:10.1016/s0041-1345(98)01365-7 · Cited by 117
Significant Role for Fas in the Pathogenesis of Autoimmune Diabetes
Su, X., Hu, Q., Kristan, J., Costa, C., Shen, Y. M., Gerő, D., Matis, L. A., & Wang, Y. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2523 · Cited by 107
Dittel, B. N., Merchant, R. M., & Janeway, C. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6392 · Cited by 97
Combadière, B., Freedman, M. L., Chen, L., Shores, E. W., Love, P. E., & Lenardo, M. J. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.5.2109 · Cited by 93
Self-citationPrimed T Cells Are More Resistant to Fas-Mediated Activation-Induced Cell Death than Naive T Cells
Inaba, M., Kurasawa, K., Mamura, M., Kumano, K., Saitō, Y., & Iwamoto, I. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1315 · Cited by 93
Dichotomy between naïve and memory CD4 + T cell responses to Fas engagement
Desbarats, J., Wade, T. K., Wade, W. F., & Newell, M. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.8104 · Cited by 90
Inhibition of Autoimmune Diabetes by Fas Ligand: The Paradox Is Solved
Kim, S., Kim, K., Hwang, D. Y., Lee, T. H., Kayagaki, N., Yagita∥, H., & Lee, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.6.2931 · Cited by 87
Kuroda, K., Yagi, J., Imanishi, K., Yan, X., Li, X. Y., Fujimaki, W., Kato, H., Miyoshi‐Akiyama, T., Kumazawa, Y., Abe, H., et al. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.4.1422 · Cited by 82
CD40 ligand inhibits Fas/CD95‐mediated apoptosis of human blood‐derived dendritic cells
Koppi, T. A., Tough‐Bement, T., Lewinsohn, D. M., Lynch, D. H., & Alderson, M. R. (1997) · European Journal of Immunology · doi:10.1002/eji.1830271212 · Cited by 78
T Cell Receptor Signals Enhance Susceptibility to Fas-mediated Apoptosis
Wong, B., Arron, J. R., & Choi, Y. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.11.1939 · Cited by 65
Kikuchi, H., Iizuka, R., Sugiyama, S., Gon, G., Mori, H., Arai, M., Mizumoto, K., & Imajoh‐Ohmi, S. (1996) · Journal of Leukocyte Biology · doi:10.1002/jlb.60.6.778 · Cited by 58
Intracellular signaling for inducible antigen receptor-mediated Fas resistance in B cells
Foote, L. C., Schneider, T. J., Fischer, G., Wang, J. K., Rasmussen, B. F., Campbell, K., Lynch, D. H., Ju, S., Marshak‐Rothstein, A., & Rothstein, T. L. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.5.1878 · Cited by 52
Wahlsten, J. L., Gitchell, H. L., Chan, C., Wiggert, B. O., & Caspi, R. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5480 · Cited by 44
Fas has a crucial role in the progression of experimental autoimmune encephalomyelitis
Okuda, Y., Bernard, C. C. A., Fujimura, H., Yanagihara, T., & Sakoda, S. (1998) · Molecular Immunology · doi:10.1016/s0161-5890(98)00049-2 · Cited by 39
Cited by
The TNF and TNF Receptor Superfamilies
Locksley, R. M., Killeen, N., & Lenardo, M. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00237-9 · Cited by 3,650
Self-citationRobbins and Cotran Pathologic Basis of Disease
Hoda, S. A., & Hoda, R. S. (2020) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqaa163 · Cited by 3,365
Immunosuppressive Strategies that are Mediated by Tumor Cells
Rabinovich, G. A., Gabrilovich, D., & Sotomayor, E. M. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141609 · Cited by 1,702
Cytokines in cancer pathogenesis and cancer therapy
Dranoff, G. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1252 · Cited by 1,573
Overview of cell death signaling pathways
Jin, Z., & El-Deiry, W. S. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.2.1508 · Cited by 1,326
Metadata
- Authors
- Siegel, R. M., Ka-Ming Chan, F., Chun, H. J., & Lenardo, M. J.
- Venue
- Nature Immunology
- Published
- 2000-12
- Volume
- 1
- Issue
- 6
- Pages
- 469-474
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W1530982587
- Cited by
- 431
- References
- 109
- FWCI
- 10.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.